Change is coming. Leronlimab will be part of the answer. There is a great force behind the scene keeping CytoDyn down. The good news is that truth and science will take leronlimab to heights unimagined so fret not the drizzle, fret the company not doing what they should right now. Tomorrows reality won't find us restricted to today's "standard of care".